Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2004
10/05/2004US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/05/2004US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/05/2004US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
10/05/2004US6800463 To assess the likely susceptibility of a virus population to a particular drug therapy; genetic engineering
10/05/2004US6800450 Vitro methods for screening for blood coagulation disorders using metal ions
10/05/2004US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor
10/05/2004US6800445 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
10/05/2004US6800444 Useful as antibacterial and other pharmaceutical agents/intermediates
10/05/2004US6800441 Heparanase specific molecular probes and their use in research and medical applications
10/05/2004US6800440 Detecting genetic disorder; obtain sample, detect bone morphogenic protein mutation, the presence of mutation indicates genetic disorder
10/05/2004US6800436 Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene
10/05/2004US6800287 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
10/05/2004CA2463719A1 Nucleotide analogs with six membered rings
10/05/2004CA2269163C Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity
10/05/2004CA2105661C A device and a method for separating liquid samples
10/03/2004CA2461445A1 Multisignal labeling reagents, and processes and uses therefor
10/02/2004CA2423327A1 Single nucleotide polymorphisms for the diagnosis and treatment of schizophirenia spectrum disorders
10/01/2004WO2005038029A2 Luciferase biosensor
10/01/2004CA2541765A1 Luciferase biosensor
09/2004
09/30/2004WO2004083902A2 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
09/30/2004WO2004083861A1 Compounds and methods for detecting tripeptidyl protease i
09/30/2004WO2004083856A1 Method of detecting colon cancer marker
09/30/2004WO2004083854A1 Identification of organic compounds capable of modulating the activity of tak1
09/30/2004WO2004083853A2 Test system for the discovery of substances for the promotion of neuraxonal growth
09/30/2004WO2004083841A1 Electrode and sensor using same
09/30/2004WO2004083822A2 Cpn60 targets for quantification of microbial species
09/30/2004WO2004083816A2 Loss of heterozygosity of the dna markers in the 12q22-23 region
09/30/2004WO2004083806A2 Autonomous genosensor apparatus and methods for use
09/30/2004WO2004083803A2 Test methods for determining the intracellular concentration of cyclic nucleotides
09/30/2004WO2004083462A2 Replication assay for discovering antiviral substances using a high throughput screening (hts) method
09/30/2004WO2004083460A1 Amp ligation assay (ala)
09/30/2004WO2004083459A1 Method and kit for a specific detection of m.tuberculosis
09/30/2004WO2004083458A1 Medical use of ras antagonists for the treatment of capillary malformation
09/30/2004WO2004083457A1 Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome
09/30/2004WO2004083456A1 Systems and methods for improving protein and milk production of dairy herds
09/30/2004WO2004083455A1 Therapeutic, prophylactic and diagnostic agents
09/30/2004WO2004083454A2 Wheel motion control input device for animation system
09/30/2004WO2004083453A1 A method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling
09/30/2004WO2004083452A1 Method of diagnosing carrier of glucose-6-phosphate dehydrogenase deficiency
09/30/2004WO2004083451A1 Analysis method
09/30/2004WO2004083449A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
09/30/2004WO2004083448A2 Molecular differences between species of the m.tuberculosis complex
09/30/2004WO2004083443A1 Single molecule amplification and detection of dna
09/30/2004WO2004083429A1 Dna fragment amplification method, reaction apparatus for amplifying dna fragment and process for producing the same
09/30/2004WO2004083422A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
09/30/2004WO2004083419A1 Fructosylamine oxidase
09/30/2004WO2004083406A2 Genes that are up- or down-regulated during differentiation of human embryonic stem cells
09/30/2004WO2004083403A2 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
09/30/2004WO2004083402A2 Spleen necrosis predictive genes
09/30/2004WO2004083399A2 Aberrantly methylated genes in pancreatic cancer
09/30/2004WO2004083398A2 Therapeutic uses of hmgn1 and hmgn2
09/30/2004WO2004083396A2 Methods for the identification of inhibitors of porphobilinogen deaminase, bifunctional purine biosynthetic protein, and a transcription factor as antibiotics
09/30/2004WO2004083393A2 Enhanced protein thermostability and temperature resistance
09/30/2004WO2004083388A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
09/30/2004WO2004083386A2 Methods of making repetitive sequences removed probes and use thereof
09/30/2004WO2004083371A2 Genes associated with obesity and methods for using the same
09/30/2004WO2004083368A2 Molecular markers for the baking quality of wheat
09/30/2004WO2004083367A2 Lyophilised cells and a method of lyophilisation for the production of said cells
09/30/2004WO2004083366A2 Methods utilizing novel target genes related to immune-mediated diseases
09/30/2004WO2004083360A1 Oxygen indicator and packaged material
09/30/2004WO2004083232A2 Receptor proteins
09/30/2004WO2004083226A1 Antimicrobial formulation comprising microthecin or derivatives thereof and their uses in prevention and therapy
09/30/2004WO2004083225A2 Probe biochips and methods for use thereof
09/30/2004WO2004083220A1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates
09/30/2004WO2004083175A2 Methods for identifying enzyme inhibitors and protein kinases
09/30/2004WO2004082617A2 Biological markers for diagnosing rheumatoid arthritis
09/30/2004WO2004082575A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 6b (pde6b)
09/30/2004WO2004082572A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87)
09/30/2004WO2004082571A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86)
09/30/2004WO2004082569A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3)
09/30/2004WO2004082568A2 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar)
09/30/2004WO2004082458A2 Tyrosine kinome
09/30/2004WO2004074501A3 A method for obtaining structural information about an encoded molecule
09/30/2004WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy
09/30/2004WO2004074429A3 Method for producing second-generation library
09/30/2004WO2004070056A3 Method to detect prostate cancer in a sample
09/30/2004WO2004066823A3 Methods and compositions for analysis of mitochondrial-related gene expression
09/30/2004WO2004065623A3 Assay for inhibitors of isph
09/30/2004WO2004064785A9 Cancer therapy sensitizer
09/30/2004WO2004064768A3 Animal model for alzheimer's disease
09/30/2004WO2004063386A3 Selecting animals for desired genotypic or potential phenotypic properties based on a single nucleotide polymorphism (snp) in intron 3 of the igf2 gene
09/30/2004WO2004063352A8 Methods and compositions for optical detection of single-stranded polynucleotides
09/30/2004WO2004062478A9 Isolation and characterization of eca1, a gene overexpressed in endometrioid carcinomas of ovary and endometrium
09/30/2004WO2004059000A3 High-throughput screening method for identifying active substances by means of co-cultivation
09/30/2004WO2004058146A3 Novel compositions and methods in cancer
09/30/2004WO2004057035A3 Method and kit for detecting replication competent adenoviruses
09/30/2004WO2004057020A8 Method of identification and quantification of proteins, isoforms of the angiotensin i converting enzyme
09/30/2004WO2004056861A3 Glycoisoforms of adiponectin and uses thereof
09/30/2004WO2004055211A3 Compositions and methods for detecting and treating neurodegenerative pathologies
09/30/2004WO2004053083A3 Modulation of fetoprotein transcription factor expression
09/30/2004WO2004048532A3 Inferring gene regulatory networks from time-ordered gene expression data using differential equations
09/30/2004WO2004046355A3 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
09/30/2004WO2004038377A3 Method for diagnosing renal diseases or predispositions
09/30/2004WO2004035827A3 Microarrays allowing molecular profiling of rheumatoid arthritis comparatively to osteoarthritis andtheir use
09/30/2004WO2004035819A8 Oligonucleotide analogues for detecting and analyzing nucleic acids
09/30/2004WO2004032842A3 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
09/30/2004WO2004031411A3 Genes and polypeptides relating to human pancreatic cancers
09/30/2004WO2004022785B1 Methods detecting, characterising and monitoring hydrocarbon reservoirs
09/30/2004WO2004021857A3 Method for retrospective birth dating of biomolecules, cells, tissues, organs and organisms
09/30/2004WO2004007752A3 System and method for determining known dna variants with temperature gradient electrophoresis